Clinical research and trials in stem cells and cancer


Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells


  • Cellular therapy
  • Tissue regeneration
  • Drug discovery

Related Conference of Clinical research and trials in stem cells and cancer

December 14-15, 2023

5th International Conference on Oncology and Cancer

Rome, Italy
February 15-16, 2024

14th World Congress on Breast Cancer Research & Therapies

Rome, Italy
February 22-23, 2024

14th World Congress on Breast Cancer

Zurich, Switzerland
March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
April 18-19, 2024

24th World Congress on Cancer and Diagnostics

Dubai, UAE
April 25-26, 2024

22nd International Conference on Cancer Biology and Cell Science

London, UK
May 16-17, 2024

44th Euro Congress on Cancer Science & Therapy

Rome, Italy
June 13-14, 2024

2nd International Conference on Cancer Biology and Therapeutics

Rome, Italy
June 13-14, 2024

21st International Conference on Breast Pathology and Cancer Diagnosis

Rome, Italy
October 24-25, 2024

3rd Experts Meeting on Cancer Medicine, Radiology & Treatment

Paris, France

Clinical research and trials in stem cells and cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in